V-125

N/A

Report date: 2022/12/29 16:33:52
NME

Base Information

Drug NameV-125
Drug Alias NameV-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor agonists
TargetsRetinoid X receptor
Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMichigan State University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLung NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A